Effectiveness of BBG

Evaluation of effectiveness of BBG in vitreoretinal surgeries - EEBVS

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCTs021180004

Enrollment

220

Registered

2019-03-13

Start date

2013-11-11

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cataract, Vitreoretinal diseases Cataract, macular hole, macular edema

Interventions

Intracameral or intravitreal injection of Brilliant blue G

E02.319.267.530.475

intraocular injection

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Needs of use of Brilliant blue G in cataract or vitreous surgery

Exclusion criteria

Exclusion criteria: Without severe ocular infections

Design outcomes

Primary

Measure	Time frame
Visual acuity	—

Secondary

Measure	Time frame
Retinal morphological changes measured byoOptical coherence tomography (OCT)	—

Contacts

Public ContactSanae Abe

Akita University Hospital

sanaeabe@med.akita-u.ac.jp+81-18-884-6167

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026